Subscribe to ENews newsletters    
Raptor's PROCYSBI(TM) Now Commercially Available in the U.S. for Nephropathic Cystinosis Patients
High Tech
Raptor's PROCYSBI(TM) Now Commercially Available in the U.S. for Nephropathic Cystinosis Patients
The company's first product, PROCYSBI &# x2122; ( cysteamine bitartrate) delayed-release capsules, has been approved by the FDA and is currently being reviewed by the European Medicines Agency, as a potential new treatment for nephropathic   04:06 Jun 19, 2013

VIVUS Announces Study Results Showing STENDRA (Avanafil) is Effective for Sexual Activity Within 15
STENDRA ( avanafil) is approved by the FDA for the treatment of erectile dysfunction in the U.S. VIVUS, through collaboration arrangements with third parties, intends to market and sell STENDRA in the U.S. and under the trade name SPEDRA in   04:06 Jun 19, 2013

VIVUS Posts Investor Presentation
Qsymia &# xAE; ( phentermine and topiramate extended-release) capsules CIV is approved in the U.S. and is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an init   03:06 Jun 19, 2013

Protalix BioTherapeutics and Brazil's Ministry of Health Enter Into Supply and Technology Transfer A
Protalix is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins expressed through its proprietary plant cell based expression system, ProCellEx &# xAE;. &# xA0; Protalix's unique   23:06 Jun 18, 2013

UCLA Presents Data on MediciNova's MN-166 in Methamphetamine Addiction at the 75th Annual Meeting of
Factors that may cause actual results or events to differ materially from those expressed or implied by these forward-looking statements, include, but are not limited to, risks of obtaining future partner or grant funding for development of   15:06 Jun 18, 2013

Biodel Announces Proposed Public Offering of Common Stock
DANBURY, Conn., June 18, 2013 ( GLOBE NEWSWIRE)- Biodel Inc. today announced that it is offering to sell, subject to market and other conditions, shares of its common stock in an underwritten public offering.   13:06 Jun 18, 2013

PositiveID Corporation Publishes Its Featured Presentation From Biodetection Technologies 2013 Confe
Statements about PositiveID's future expectations, including, without limitation, the likelihood that results from M-BAND are reported via a secure wireless network in real time to give an accurate and up to date status for fielded instrume   13:06 Jun 18, 2013

Global Data Center Services Provider CyrusOne to Participate in Nebraska Data Center Day
CyrusOne specializes in highly reliable enterprise-class, carrier-neutral data center properties.   12:52 Jun 18, 2013

Integrated Environmental Technologies, Ltd. Announces Asset Purchase Agreement and Update on Oil and
Integrated Environmental Technologies, Ltd., is a publicly-traded company that operates through its wholly-owned operating subsidiary, I.E.T., Inc. &# xA0; The Company sells anolyte disinfecting solution under the EcaFlo &# x2122; and Excel   11:38 Jun 18, 2013

Photo Release -- Vision Systems to Open Its First-Ever U.S. SPD-SmartGlass Factory
The new factory was highlighted today at the Paris Air Show by Florida Governor Rick Scott and Vision Systems President and CEO Carl Putman, with Research Frontiers President and CEO Joseph M. Harary and others in attendance for this specia   10:38 Jun 18, 2013

WCUI's Targeted UV Phototherapy Technology Receives Patent Allowance for Patient Safety Innovation
" Psoria-Light is composed of several exciting new patent pending technologies that together deliver our breakthrough targeted monochromatic narrow-band UVB ( NB-UVB) and PUVA ( UVA+ psoralen) treatments to patients", stated Scot Johnson, C   08:38 Jun 18, 2013

Intellect Neurosciences Engages Evli Corporate Finance to Explore Strategic Alternatives to Maximize
The statements in this release and oral statements made by representatives of Intellect Neurosciences relating to matters that are not historical facts ( including, without limitation, those regarding future performance or financial results   08:38 Jun 18, 2013

Context Matters Appoints Dr. Paul Greenberg to Its Board of Advisors
NEW YORK, June 18, 2013 ( GLOBE NEWSWIRE)- Context Matters announces the addition of Dr. Paul Greenberg to its Board of Advisors.   06:38 Jun 18, 2013

Gevo Resumes Commercial Production of Isobutanol
ENGLEWOOD, Colo., June 18, 2013 ( GLOBE NEWSWIRE)- Gevo, Inc. today announced that it has resumed commercial production of isobutanol at its Luverne, Minn. plant in single train mode, successfully utilizing its proprietary Gevo Integrated F   06:26 Jun 18, 2013

EDAP Granted European Market Clearance for Focal.One(R)
Positions Focal. One Robotic HIFU Device for Commercialization LYON, France, June 18, 2013 ( GLOBE NEWSWIRE)- EDAP TMS SA, the global leader in therapeutic ultrasound, announced today that it received CE Mark ( European regulatory approval)   06:07 Jun 18, 2013

...

News Copyright © 2006 Interest!ALERT

 

InterestAlert

Holiday Ideas
  Holiday Ideas

Top News
  Front Page
  Late Breaking
  National
  World News
  Business
  Opinions
  Politics
  High Tech
  Health
  Sports
  California News
  Entertainment
Women's News
  Women in the News
  Women in Sport
  Women in Politics
Politics
  Democrats
  Republicans
Sport
  Baseball
  Basketball
  Boxing
  Cricket
  Football
  Golf
  Hockey
  Olympics
  Other Sports
  Racing
  Rugby
  Soccer
  Tennis
  Track & field
Industry News
  Advertising
  Aerospace & Defense
  Agriculture
  Auto
  Aviation
  Banking & Finance
  Chemical
  Computer & Electronics
  Construction
  Education
  Entertainment
  Environment
  Food & Beverage
  Gambling
  Healthcare
  Household
  Insurance
  Internet
  Leisure
  Machinery
  Maritime
  Medical
  Mining
  Oil & Energy
  Paper
  Publishing
  Real Estate
  Restaurants
  Retail
  Telecom
  Textile
  Tobacco
  Transportation
  Utilities


Free news content on your site

About Us Content Solutions: News Experience | SiteNews
  Copyright © 1996-2012 Interest!ALERT
Legal Notices and Terms of Use